Evidence map›Paper›PMID 38827289›Full record

ArticlePeerJ2024

Linxiao Wang, Rui Zhao, Xuemei Li, Pei Shao, Jiangang Xie, Xiangni Su, Sijia Xu, Yang Huang, Shanbo Hu

Abstract read
In one paragraph

Article in PeerJ, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Oral Administration ofAntioxidants (Basel, Switzerland) · 2025
    Article
  3. Review
  4. Article
  5. Frontiers in immunology · 2025
    Article
  6. Frontiers in microbiology · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Linxiao Wang *College of Life Sciences, Northwest University, Xi'an, Shaanxi, China.
Rui Zhao *College of Life Sciences, Northwest University, Xi'an, Shaanxi, China.
Xuemei LiCollege of Life Sciences, Northwest University, Xi'an, Shaanxi, China.
Pei ShaoSchool of Nursing, Air Force Medical University, Xi'an, Shaanxi, China.
Jiangang XieDepartment of Emergency, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Xiangni SuSchool of Nursing, Air Force Medical University, Xi'an, Shaanxi, China.
Sijia XuSchool of Nursing, Air Force Medical University, Xi'an, Shaanxi, China.
Yang HuangDepartment of Emergency, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Shanbo HuSchool of Nursing, Air Force Medical University, Xi'an, Shaanxi, China.

Funding

General Project Surface Project in Shaanxi ProvinceKey Research and Development Program of Shaanxi ProvinceNatural Science Foundation Project in Shaanxi ProvinceThe Medjaden Academy & Research Foundation for Young Scientists
6 · The paper itself

Abstract

Background: Survivors of sepsis may encounter cognitive impairment following their recovery from critical condition. At present, there is no standardized treatment for addressing sepsis-associated encephalopathy. Methods: Female C57BL/6 mice were randomly divided into three groups: sham surgery, cecal ligation and puncture (CLP), and CLP+LGG. Cognitive behavior was assessed longitudinally at 7-9d, 14-16d, and 21-23d after surgery using an open field test and novel object recognition test. The impact of LGG treatment on pathological changes, the expression level of brain-derived neurotrophic factor (BDNF), and the phosphorylation level of the TrkB receptor (p-TrkB) in the hippocampus of mice at two weeks post-CLP (16d) were evaluated using histological, immunofluorescence, immunohistochemistry, and western blot analyses. Results: The CLP surgery induced and sustained cognitive impairment in mice with sepsis for a minimum of three weeks following the surgery. Compared to mice subjected to CLP alone, the administration of LGG improved the survival of mice with sepsis and notably enhanced their cognitive functioning. Moreover, LGG supplementation significantly alleviated the decrease in hippocampal BDNF expression and p-TrkB phosphorylation levels caused by sepsis, preserving neuronal survival and mitigating the pathological changes within the hippocampus of mice with sepsis. LGG supplementation mitigates sepsis-related cognitive impairment in mice and preserves BDNF expression and p-TrkB levels in the hippocampus.

Indexed as

Brain-Derived Neurotrophic FactorCognitive DysfunctionHippocampusLacticaseibacillus rhamnosusMice, Inbred C57BLProbioticsSepsisAnimalsDisease Models, AnimalFemaleMicePhosphorylationReceptor, trkBSepsis-Associated EncephalopathyBdnf protein, mouseBrain-Derived Neurotrophic FactorReceptor, trkBBDNFCognitionHippocampusLactobacillus rhamnosus GGSepsis

Identifiers

PMID38827289
PMCPMC11141560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.